Planning a postdoc before moving to industry? Think again
Experience as a postdoctoral researcher might not fast-track your career outside academia, Julie Gould discovers.
Nessa Carey, a UK entrepreneur and technology-transfer professional whose career has straddled academia and industry, including a senior role at Pfizer, shares insider knowledge on how industry employers often view postdoctoral candidates. She also offers advice on CVs and preparing for interviews.
\u201cIt is very tempting sometimes for people to keep on postdoc-ing, especially if they have a lab head who has a lot of rolling budget and who likes having the same postdocs there, because they're productive and they know them,\u201d she says. \u201cThat\u2019s great for the lab head. It\u2019s typically very, very bad for the individual postdoc,\u201d she adds.
Carey is joined by Shulamit Kahn, an economist at Boston University in Massachusetts, who co-authored a 2017 paper about the impact of postdoctoral training on early careers in biomedicine1.
According to the paper, published in Nature Biotechnology, employers did not financially value the training or skills obtained during postdoc training. \u201cBased on these findings, the majority of PhDs would be financially better off if they skipped the postdoc entirely,\u201d it concludes.
Malcolm Skingle, academic liaison at GlaxoSmithKline, adds: \u201cYou really will get people who have done their PhD, they\u2019ve done a two-year postdoc, they think they\u2019re pretty much going to run the world and single-handedly develop a drug.
\u201cThey have got no idea how difficult drug discovery is, and their place in that very big jigsaw.\u201d
\u201cAnd why don\u2019t postdocs get great salaries straightaway? Well, actually, they haven\u2019t proven themselves in our environment, where, if they\u2019re any good, then their salaries will go up quite quickly.\u201d
Hosted on Acast. See acast.com/privacy for more information.